RecallDepth
Class II Ongoing

Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-2277-7.

Company
Teva Pharmaceuticals Usa, Inc
Recall Initiated
October 13, 2025
Posted
November 12, 2025
Recall Number
D-0151-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
4680 cartons
Firm Location
Parsippany, NJ, United States

Reason for Recall

Subpotent drug; Clavulanate Potassium component

Distribution

Distributed in three (3) States: MS, OH, CA.

Lot / Code Info

Lot # 100062316, Exp Date: 01/2026

More recalls by Teva Pharmaceuticals Usa, Inc

View all recalls by this company →

Other recent Class II Drug recalls